Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B known ✓ | P35368 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL87312 | 0.97 | CYP3A4 (0.32) | CYP3A4ADRA1DADRA1AADRA1B | |
| Bromide SCHEMBL1045354 | 0.94 | CYP3A4 (0.31) | CYP3A4ADRA1DADRA1AADRA1B | |
| Iodide SCHEMBL2341578 | 0.94 | CYP3A4 (0.31) | CYP3A4ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL28734875 | 0.89 | — | — | |
| SCHEMBL16681715 | 0.89 | — | — | |
| SCHEMBL16681716 | 0.87 | — | — | |
| SCHEMBL28255087 | 0.85 | — | — | |
| SCHEMBL2690793 | 0.85 | — | — | |
| SCHEMBL27921165 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL4367848 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118988016-A | Gel polybenzimidazole ion solvent membrane with double-crosslinked cation network structure, preparation method thereof and application of gel polybenzimidazole ion solvent membrane in hydrogen production by alkaline water electrolysis | 浙江工业大学 | 2024-11-22 | — | — | CN | claimed |
| CN-117105867-A | Caffeic acid salt ionic liquid and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2023-11-24 | — | — | CN | claimed |
| CN-108383792-B | Diallyl imidazole methoxyacetate, lignin solvent, preparation and application | 河南科技大学 | 2020-05-05 | — | — | CN | claimed |
| CN-108383792-A | A kind of diallyl imidazoles methoxyacetic acid salt, lignin solvent and preparation and application | 河南科技大学 | 2018-08-10 | — | — | CN | claimed |
| US-20150126626-A1 | LIQUID CATALYST FOR METHANATION OF CARBON DIOXIDE | WUHAN KAIDI ENGINEERING TECHNOLOGY RESEARCH INSTITUTE CO., LTD. (CN) | 2015-05-07 | — | — | US | claimed |
| US-20100261945-A1 | METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND | SAMSUNG ENGINEERING CO., LTD. (KR) | 2010-10-14 | — | — | US | claimed |
| CN-101400836-A | Method for the production of molded bodies from proteins having ionic liquids | THUERINGISCHES INST TEXTIL (DE) | 2009-04-01 | — | — | CN | claimed |
| CN-118988016-A | Gel polybenzimidazole ion solvent membrane with double-crosslinked cation network structure, preparation method thereof and application of gel polybenzimidazole ion solvent membrane in hydrogen production by alkaline water electrolysis | 浙江工业大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-117105867-A | Caffeic acid salt ionic liquid and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2023-11-24 | — | — | CN | disclosed |
| CN-114409567-B | Method for preparing 1-chloroaldoxime | 浙江锦华新材料股份有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-110475765-B | Preparation method of amide compound | 广荣化学株式会社 | 2023-04-07 | — | — | CN | disclosed |
| CN-114409567-A | Method for preparing 1-chloroacetaldoxime | 浙江锦华新材料股份有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-10913724-B2 | Production method for amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2021-02-09 | — | — | US | disclosed |
| US-6472565-B1 | Method for producing aldehydes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-10-29 | — | — | US | disclosed |
| US-6114272-A | CATALYST FOR PREPARING ALDEHYDES BY HYDROFORMYLATION OF OLEFINS OR OLEFINICALLY UNSATURATED COMPOUNDS | CELANESE GMBH (DE) | 2000-09-05 | — | — | US | disclosed |
| US-6103908-A | HYDROFORMYLATION CATALYSTS; SIMPLIFICATION, EFFICIENCY | CELANESE GMBH (DE) | 2000-08-15 | — | — | US | disclosed |
| US-6025529-A | CATALYTIC HYDROFORMYLATION OF OLEFIN UNSATURATED COMPOUNDS IN THE PRESENCE OF A MIXTURE HAVING A RHODIUM COMPOUND AND A NONAQUEOUS IONIC LIGAND QUATERNARY AMMONIUM AND/OR PHOSPHONIUM CATION AND SULFONATED TRIARYLPHOSPHINE ANION | CELANESE GMBH (DE) | 2000-02-15 | — | — | US | disclosed |
| CN-1223908-A | Nonaqueous ionic ligand liquids, process for preparing them and their use as catalyst constituents | CELANESE GMBH (DE) | 1999-07-28 | — | — | CN | disclosed |
| US-4463072-A | ALUMINUM ANODES; STABILIZATION AGAINST ELECTROCHEMICAL OXIDATION AND REDUCTION | ALLIED CORPORATION (US) | 1984-07-31 | — | — | US | disclosed |
| US-4463071-A | STABILIZATION AGAINST ELECTROCHEMICAL OXIDATION AND REDUCTION | ALLIED CORPORATION (US) | 1984-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913724-B2 | Production method for amidate compound | NAAA, PAM, CCKBR | ADRA1D 2670/4885ADRA1A 1990/4885ADRA1B 2388/4885 |
| US-20100261945-A1 | METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND | AHR, ALK, PAH | ADRA1D 1621/4885ADRA1A 1978/4885ADRA1B 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.